Cancer screening and diagnostics market shows steady growth amid technological innovation
This article was originally published in Clinica
Executive Summary
The combined market for in vitro cancer diagnostics and mammography products in the major industrialised countries is set to grow at an average compound annual rate of 7.4% over the next five years, reaching $2.5 billion by 2002.